Edastar Injection contains Edaravone, a neuroprotective agent used in the treatment of acute ischemic stroke and amyotrophic lateral sclerosis (ALS). Edaravone works by acting as a free radical scavenger, reducing oxidative stress that damages neurons during stroke or in neurodegenerative diseases.
Edastar helps minimize brain injury after stroke by preventing lipid peroxidation and maintaining cellular integrity. In ALS, it may help slow disease progression and preserve muscle function. It’s typically used in hospital settings under specialist supervision.
✅ Acute Ischemic Stroke — reduces brain cell damage when administered early
✅ Amyotrophic Lateral Sclerosis (ALS) — slows the decline in physical function in ALS patients
✅ Neuroprotection — limits oxidative injury to brain and nerve cells
Edastar Injection contains Edaravone, a neuroprotective agent used in the treatment of acute ischemic stroke and amyotrophic lateral sclerosis (ALS). Edaravone works by acting as a free radical scavenger, reducing oxidative stress that damages neurons during stroke or in neurodegenerative diseases.
Edastar helps minimize brain injury after stroke by preventing lipid peroxidation and maintaining cellular integrity. In ALS, it may help slow disease progression and preserve muscle function. It’s typically used in hospital settings under specialist supervision.
✅ Acute Ischemic Stroke — reduces brain cell damage when administered early
✅ Amyotrophic Lateral Sclerosis (ALS) — slows the decline in physical function in ALS patients
✅ Neuroprotection — limits oxidative injury to brain and nerve cells